Fuji Pharma Co. Ltd
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, and information regarding pharmace… Read more
Market Cap & Net Worth: Fuji Pharma Co. Ltd (FUP)
Fuji Pharma Co. Ltd (F:FUP) has a market capitalization of $303.74 Million (€295.91 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #16601 globally and #1719 in its home market, demonstrating a -4.72% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fuji Pharma Co. Ltd's stock price €12.10 by its total outstanding shares 24455235 (24.46 Million).
Fuji Pharma Co. Ltd Market Cap History: 2015 to 2026
Fuji Pharma Co. Ltd's market capitalization history from 2015 to 2026. Data shows growth from $206.97 Million to $303.74 Million (4.97% CAGR).
Fuji Pharma Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fuji Pharma Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Fuji Pharma Co. Ltd's market cap is 0.00 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.09x
Fuji Pharma Co. Ltd's market cap is 0.09 times its annual earnings
10.29x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $268.94 Million | $34.23 Billion | $2.12 Billion | 0.01x | 0.13x |
| 2017 | $396.55 Million | $35.39 Billion | $3.30 Billion | 0.01x | 0.12x |
| 2018 | $340.64 Million | $37.91 Billion | $3.37 Billion | 0.01x | 0.10x |
| 2019 | $268.60 Million | $36.28 Billion | $2.96 Billion | 0.01x | 0.09x |
| 2020 | $239.73 Million | $33.79 Billion | $2.08 Billion | 0.01x | 0.11x |
| 2021 | $194.55 Million | $33.99 Billion | $2.43 Billion | 0.01x | 0.08x |
| 2022 | $179.48 Million | $35.43 Billion | $2.70 Billion | 0.01x | 0.07x |
| 2023 | $278.64 Million | $40.89 Billion | $3.44 Billion | 0.01x | 0.08x |
| 2024 | $240.99 Million | $46.14 Billion | $6.15 Billion | 0.01x | 0.04x |
| 2025 | $256.05 Million | $51.68 Billion | $3.00 Billion | 0.00x | 0.09x |
Competitor Companies of FUP by Market Capitalization
Companies near Fuji Pharma Co. Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Fuji Pharma Co. Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Fuji Pharma Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Fuji Pharma Co. Ltd's market cap moved from $206.97 Million to $ 303.74 Million, with a yearly change of 4.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €303.74 Million | +18.63% |
| 2025 | €256.05 Million | +6.25% |
| 2024 | €240.99 Million | -13.51% |
| 2023 | €278.64 Million | +55.24% |
| 2022 | €179.48 Million | -7.74% |
| 2021 | €194.55 Million | -18.85% |
| 2020 | €239.73 Million | -10.75% |
| 2019 | €268.60 Million | -21.15% |
| 2018 | €340.64 Million | -14.10% |
| 2017 | €396.55 Million | +47.45% |
| 2016 | €268.94 Million | +29.94% |
| 2015 | €206.97 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Fuji Pharma Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $303.74 Million USD |
| MoneyControl | $303.74 Million USD |
| MarketWatch | $303.74 Million USD |
| marketcap.company | $303.74 Million USD |
| Reuters | $303.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.